Todd Sone
Director at Ayala Pharmaceuticals, Inc. (AYLA)
Todd Sone has filed 1 insider report with the SEC since June 2021, as director at Ayala Pharmaceuticals, Inc. (AYLA). The latest filing, on June 14, 2021, reports grant or award at Ayala Pharmaceuticals, Inc. (AYLA).
- Filings
- 1
- Companies
- 1
- Bought on market
- None
- Sold on market
- None
Companies where Todd Sone is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | Jun 14, 2021 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
Questions about Todd Sone
- What is Todd Sone's role at Ayala Pharmaceuticals, Inc.?
- Todd Sone reports to the SEC as director at Ayala Pharmaceuticals, Inc. (AYLA), according to the latest filing on June 14, 2021.
- Has Todd Sone bought or sold stock recently?
- No open-market purchases or sales by Todd Sone are on file. The filings report grant or award.
- How do I get alerts when Todd Sone files?
- Follow Todd Sone on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Todd Sone (SEC CIK 0001811299). Totals count each trade once, skipping amendments whose original is on file, from Jun 14, 2021 on. View on SEC EDGAR · Get this as JSON